◆ 会议时间：2022年9月28日至10月1日
◆ 会议地点：美国 迈阿密

◆ 会议简介：

2022年世界分子影像学大会(WMIC2022)将于2022年9月28日至10月1日在美国迈阿密举行。
世界分子影像大会（WMIC）是由世界分子影像学会(WMIS)组织，由在分子影像领域被公认为拥有专业知识的资深学术和行业专业人士领导主持的国际盛会，每年都有数千名来自世界各地的相关专业人士代表共聚一堂，一起分享宣探讨分子影像学的最新进展、创新理念和前沿研究；WMIC的与会者包括分子影像相关领域的科学家、医生以及与分子影像相关的主要设备厂家等等。

世界分子影像学会（WMIS）成立于2011年，是通过整合分子成像学会（AMI）和分子成像协会（SMI）而组建的专注于推进分子影像（MI）领域发展的国际科学教育组织（未经许可禁止复制摘录转载本站任何内容-领域国际医学会议网）。

WMIC 2022 - World Molecular Imaging Congress
Date: September 28 to October 1, 2022
Location: Miami, Florida, USA
In-person and virtual sessions

The World Molecular Imaging Congress(WMIC) brings together thousands of people from across the globe who represent the entire spectrum of Molecular Imaging. These individuals gather at WMIC to exchange ideas and foster innovation. The scientific and educational sessions are replete with leaders in the field and young scientists alike, each of whom has made significant contributions to our understanding of biology, advanced technology innovation, and/or evaluated new developments in the clinic. These sessions are complemented by thousands of abstracts that detail advances and highlight the latest developments in Molecular Imaging. Our industry exhibitors and sponsors showcase their innovations in the exhibition hall and lecture hall, detailing advances that will refine your animal models, accelerate your research, and improve clinical care. Each WMIC session is packed with innovative ideas and cutting-edge research.

Molecular Imaging is a window into biology that enables discovery. We use these windows to investigate new biology and increase understanding, and the better we understand biological processes of living systems, with all of the contextual influences intact, the more effective our therapies will be in the clinic. Molecular Imaging lies at the heart of precision medicine. WMIC is the event that showcases all of the innovations in Molecular Imaging and shows the utility of novel imaging strategies in clinical investigation and the study of disease. 

摘要征集：

Please plan to start early when writing and submitting abstracts.

• Start early by gathering current information about authors and affiliations. You may also return to the submission site at a later date to upload your final documents or make any changes.
• Starting the writing process early provides time for review by your colleagues and co-authors, which can substantially improve the quality of an abstract.

Title

Submit your title in mixed case and sentence format. How you choose to enter your information is how it will appear to the public if your abstract is selected. Your title should include specific information about the disease state or biological process, imaging modality or modalities, and/or the type of imaging subject (e.g., chemical, in vitro, in vivo animal, in vivo human). Abstract reviewers often suggest preferences for abstracts to review based on the abstract titles. Therefore, it is in your best interest to provide specific information in your title to match the best reviewers for your abstract.

Main Text

• The abstract should clearly indicate the hypothesis or design objective of the study.
• Abstracts should directly describe the innovation of the study.
• Results should be substantive and not just implied. Validation studies should be included when available.
• Studies that are completed are often ranked higher than studies that are still in progress. Therefore, focus on accomplished studies rather than future studies.
• To encourage a blinded review in which reviewers are not aware of the identity of the abstract authors do not include author or co-author information in the body of the abstract. Use a passive voice when listing information that will be referenced. For example, “We used our technique…[1]” should be rephrased as “A technique was used…[1]”.
• Evident bias in favor of a particular product or company is grounds for rejection. Describing the use of a particular company’s products or equipment in itself does not represent bias. Non-data-driven statements of superiority, however, are considered biased.

Character Limit

There is a limit of 600 words (about 3200 – 4000 characters depending on word usage) for the text of your submission. The character count includes spaces. You will be advised of your character count usage throughout the submission process as you save and move to the next step. One image with a description is permitted per submission, and the description will not count against your character total.

Abstract Limit

There are no restrictions on the number of submissions you may submit or on the number of submissions you may present. However, the WMIC will screen for and remove duplicate abstract submissions from review.

References

References to published literature are expected. The reference format can be truncated to save page space if needed, but the truncated format should provide sufficient information for locating the publication. A reference to work that has not yet been accepted for publication is not allowed.

Persuasive Data File

Very few abstracts without a Persuasive Data file were accepted for oral presentations at the past WMIC meetings, and this trend is expected to continue for the WMIC 2022 meeting. Therefore, please include a Persuasive Data file if you would like your abstract to be considered for an oral presentation. Persuasive data should include figure captions that explain the results of the figure without requiring the reviewer to re-read the main text.

Uploading Documents

When uploading documents during the submission process, the title of the document can be viewed by reviewers, and therefore should not include information that would identify the authors of the abstract. For example, a document called “John Smith Supplementary Data” should be uploaded as “Supplementary Data for Abstract XYZ.”

Final Tasks

Before submitting, review your full abstract for spelling, typos, and omitted information, and check the spelling of all author names and affiliations. How you choose to enter your information is how it will appear to the public if your abstract is selected. Please submit your personal financial disclosure in a timely manner. It is the submitting author’s responsibility to remind all co-authors that they need to submit their financial disclosures; an email is auto-generated to all co-authors after the abstract has been successfully submitted.

Notifications

Notifications will be emailed by the end of June. If you do not receive your notification by July 11, 2022, please contact WMIS, at SpeakerInfo@wmis.org

Withdraw Deadline

The deadline to withdraw an abstract is August 31, 2022.

Embargo Policy

Abstract bodies, images, and tables will be unavailable until September 14, 2022, when complete data will be made available for viewing. Prior to that date, only abstract titles and (co)author information will be available.

If you have questions regarding the submission criteria or questions about the meeting, please contact WMIS at speakerinfo@wmis.org.

注册费：

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。